Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Minority Interest (2016 - 2018)

Traws Pharma's Minority Interest history spans 6 years, with the latest figure at $830000.0 for Q1 2018.

  • Quarterly results put Minority Interest at $830000.0 for Q1 2018, changed 0.0% from a year ago — trailing twelve months through Mar 2018 was $830000.0 (changed 0.0% YoY), and the annual figure for FY2017 was $830000.0, changed 0.0%.
  • Minority Interest for Q1 2018 was $830000.0 at Traws Pharma, roughly flat from $830000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $874000.0 in Q4 2014 to a low of $394000.0 in Q3 2014.
  • The 5-year median for Minority Interest is $830000.0 (2015), against an average of $761823.5.
  • Peak annual rise in Minority Interest hit 110.66% in 2015, while the deepest fall reached 5.03% in 2015.
  • Year by year, Minority Interest stood at $874000.0 in 2014, then dropped by 5.03% to $830000.0 in 2015, then changed by 0.0% to $830000.0 in 2016, then changed by 0.0% to $830000.0 in 2017, then changed by 0.0% to $830000.0 in 2018.
  • According to Business Quant data, Minority Interest over the past three periods came in at $830000.0, $830000.0, and $830000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.